Cambridge Healthtech Institute’s 5th Annual

Immuno-Oncology Biomarkers

Predictive Biomarkers and Companion Diagnostics in Immunotherapy

June 17, 2021

 

As pharmaceutical and biotechnology companies increase their investment in immuno-oncology programs to facilitate rapid development of novel immunotherapies, there is increasing pressure to discover and validate relevant biomarkers. Cambridge Healthtech Institute’s 5th Annual Immuno-Oncology Biomarkers conference will bring together biomarker experts from industry and academia to address rapid development of predictive and prognostic IO biomarkers, utility of these biomarkers in clinical trials, and their potential as companion diagnostics.  

 

Coverage will include, but is not limited to:

 

  • Integrative biomarker analysis from immunology, oncology, and “omics” data
  • Immune-based biomarkers to predict clinical response
  • Profiling of tumor-infiltrating immune cells
  • Microsatellite instability and mismatch repair deficiency biomarkers
  • Immune monitoring, immunosequencing, and immunophenotyping
  • Liquid biopsy for immuno-oncology
  • Neoepitope profiling
  • Mutational burden in tumors
  • Biology of tumor microenvironment
  • PD-L1 as a predictive biomarker and companion diagnostic
  • Mechanism of non-response: resistance or lack of efficacy
  • Development of companion diagnostics assays

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is January 29, 2021.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:

Julia Boguslavsky

Executive Director, Conferences

Cambridge Healthtech Institute

Email: juliab@healthtech.com

 

For partnering and sponsorship information, please contact:

Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: 781-247-6286

Email: reymael@healthtech.com